FDA
- Status: approved
🇺🇸 TNF Inhibitor in United States
TNF Inhibitor (tnf-inhibitor) regulatory status in United States.
Marketing authorisation
Pricing & reimbursement
- annual_list: USD 17767.00 per year
TNF Inhibitor in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is TNF Inhibitor approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for TNF Inhibitor in United States?
Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.
What does TNF Inhibitor cost in United States?
annual_list: USD 17767.00 per year. Final patient cost depends on reimbursement and any patient access scheme.